Pre-operative sildenafil and pulmonary endothelial-related complications following cardiopulmonary bypass: A randomised trial in children undergoing cardiac surgery

Anaesthesia

Volumn 66, Issue 6, 2011, Pages 472-480

  Vassalos, A ^a   Peng, E ^b   Young, D ^c   Walker, S ^d   Pollock, J ^b   Macarthur, K ^b   Lyall, F ^d   Danton, M H D ^b  

^a ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRATE; PLACEBO; SILDENAFIL;

ARTICLE; BLOOD OXYGENATION; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART OUTPUT; HUMAN; INFANT; LUNG VASCULAR RESISTANCE; MALE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; CARDIOPULMONARY BYPASS; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; HEART SEPTAL DEFECTS; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; OXYGEN INHALATION THERAPY; PIPERAZINES; POSTOPERATIVE CARE; PREOPERATIVE CARE; PULMONARY ARTERY; PURINES; SULFONES; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 79956154889     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2011.06702.x     Document Type: Article

References (25)

1. Schulze-Neick I, Li J, Penny DJ, Redington AN,. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. Journal of Thoracic and Cardiovascular Surgery 2001; 121: 1033-9.
2. Schulze-Neick I, Hartenstein P, Li J, et al., Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003; 108 (Suppl. II): 167-73.
3. Smith H, Canter J, Christian K, et al., Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. Journal of Thoracic and Cardiovascular Surgery 2006; 132: 58-65.
4. Wessel D, Adatia I, Giglia TM, Thompson JE, Kulik TJ,. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88: 2128-38. (Pubitemid 23326092)
5. Asimakopoulos G, Smith PLC, Ratnatunga CP, Taylor KM,. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Annals of Thoracic Surgery 1999; 68: 1107-15. (Pubitemid 29530528)
6. Petros AJ,. Down-regulation of endogenous nitric oxide production after prolonged administration. Lancet 1994; 344: 191. (Pubitemid 24218892)
7. Atz A, Wessel D,. Sildenafil Ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999; 91: 307-10. (Pubitemid 29307366)
8. Corbin JD, Francis SH,. Cyclic GMP phosphodiesterase-5: target of sildenafil. Journal of Biological Chemistry 1999; 274: 13729-32.
9. Trachte AL, Lobato EB, Urdaneta F, et al., Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Annals of Thoracic Surgery 2005; 79: 194-7. (Pubitemid 40037471)
10. Karatza AA, Bush A, Magee AG,. Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. International Journal of Cardiology 2005; 100: 267-73.
11. Lange R, Guenther T, Busch R, Hess J, Schreiber C,. The presence of Down syndrome is not a risk factor in complete atrioventricular septal repair. Journal of Thoracic and Cardiovascular Surgery 2007; 134: 304-10. (Pubitemid 47088564)
12. Roberts N, Westrope C, Pooboni S, et al., Venovenous extracorporeal membrane oxygenation for respiratory failure in inotrope dependent neonates. American Society for Artificial Internal Organs 2003; 49: 568-71. (Pubitemid 37129280)
13. Valdes-Cruz L, Horowitz S, Mesel E, Sahn D, Fisher D, Larson D,. A pulsed Doppler echocardiographic method for calculating pulmonary and systemic blood flow in atrial level shunts: validation studies in animals and initial human experience. Circulation 1984; 69: 80-6. (Pubitemid 14215865)
14. Cheung M, Smallhorn J, Vogel M, Van Arsdell G, Redington A,. Disruption of the ventricular myocardial force-frequency relationship after cardiac surgery in children: non-invasive assessment by means of tissue Doppler imaging. Journal of Thoracic and Cardiovascular Surgery 2006; 131: 625-31.
15. Stocker C, Penny D, Brizard C, Cochrane A, Soto R, Shekerdemian L,. Intravenous sildenafil and inhaled nitric oxide: a randomized trial in infants after cardiac surgery. Intensive Care Medicine 2003; 29: 1996-2003. (Pubitemid 37487135)
16. Humpl T, Reyes J, Holtby H, Stephens D, Adatia I,. Beneficial effect of oral sildenafil therapy on childhood pulmonary artery hypertension. Circulation 2005; 111: 3274-80.
17. Reffelmann T, Kloner R,. Therapeutic potential of phosphodiesterase-5 inhibition for cardiovascular disease. Circulation 2003; 108: 239-44. (Pubitemid 36871309)
18. Gillies H, Roblin D, Jackson G,. Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. International Journal of Cardiology 2002; 86: 131-41. (Pubitemid 35284801)
19. Kothari S, Duggal B,. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Indian Heart Journal 2002; 54: 404-9. (Pubitemid 35447129)
20. Gorscan J, Strum D, Mandarino W, Gulati V, Pinsky M,. Quantitative assessment of alterations in regional left ventricular contractility by colour-coded tissue Doppler echocardiography: comparison with sonomicrometry and pressure-volume relations. Circulation 1997; 95: 2423-33. (Pubitemid 27224738)
21. Derumeaux G, Ovize M, Loufoua J, et al., Doppler imaging quantifies regional wall motion during myocardial ischaemia and reperfusion. Circulation 1998; 97: 1970-7. (Pubitemid 28222192)
22. Paulus W, Bronzwaer J,. Myocardial contractile effects of nitric oxide. Heart Failure Reviews 2002; 7: 371-83. (Pubitemid 35396469)
23. Borlaug B, Melenovsky V, Marhin T, Fitzgerald P, Kass D,. Sildenafil inhibits β-adrenergic-stimulated cardiac contractility in humans. Circulation 2005; 112: 2642-9. (Pubitemid 41532601)
24. Takimoto E, Champion H, Belardi D, et al., cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS-3 dependent mechanism. Circulation Research 2005; 96: 100-9. (Pubitemid 40095759)
25. Kleinsasser A, Loeckinger A, Hoermann C, et al., Sildenafil modulates hemodynamics and pulmonary gas exchange. American Journal of Respiratory and Critical Care Medicine 2001; 163: 339-43. (Pubitemid 32158509)